Stewart Matthew C
Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois, 1008 West Hazelwood Drive, Urbana, IL 61802, USA.
Vet Clin North Am Equine Pract. 2011 Aug;27(2):393-9. doi: 10.1016/j.cveq.2011.07.001.
This article focuses on current issues facing cell-based therapies in equine practice and future studies validating the use of stem cells and related biologic therapies for the treatment of musculoskeletal conditions in the horse. Issues raised include the characterization and use of tissue- and anatomic location-specific mesenchymal stem cell (MSC) sources, the putative advantages and feasibility of allogeneic embryonic stem cell and MSC products, the technical advantages and performance of cell-based biologic agents that do not require extensive ex vivo manipulation, the regulation of MSC homing, potential nonorthopaedic stem cell applications, and the logistics required to demonstrate cell-based therapy efficacy in horses.
本文聚焦于马医学实践中基于细胞的疗法所面临的当前问题,以及验证使用干细胞和相关生物疗法治疗马的肌肉骨骼疾病的未来研究。提出的问题包括组织和解剖位置特异性间充质干细胞(MSC)来源的特性及应用、同种异体胚胎干细胞和MSC产品的假定优势与可行性、无需大量体外操作的基于细胞的生物制剂的技术优势和性能、MSC归巢的调控、潜在的非骨科干细胞应用,以及证明马的基于细胞疗法疗效所需的后勤保障。